Elite Pharmaceuticals, Inc. (ELTP) Q2 Revenue Rose 10.4% to $40.1M

Elite Pharmaceuticals reported fiscal Q2 2027 revenue of $40.1M, up $3.8M or approximately 10.4% year over year, and operating income of $9.9M, up $1.7M or approximately 21%. Net income attributable to common shareholders was $17.3M; no prior-period comparison was provided.Material DetailsContext b…